• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

tert-butyl 3-sulfanyl-1H,5H,6H,7H,8H,8aH-imidazo[1,5-a]pyrazine-7-carboxylate (CAS No. 1384427-68-2): An Overview of a Promising Compound in Medicinal Chemistry

tert-butyl 3-sulfanyl-1H,5H,6H,7H,8H,8aH-imidazo[1,5-a]pyrazine-7-carboxylate (CAS No. 1384427-68-2) is a complex organic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of imidazopyrazines, which are known for their diverse pharmacological properties. The presence of a tert-butyl group and a sulfanyl substituent on the imidazopyrazine core imparts specific chemical and biological characteristics that make it an intriguing candidate for further research and development.

The imidazopyrazine scaffold is a privileged structure in medicinal chemistry, often found in compounds with anti-inflammatory, antiviral, and anticancer properties. The sulfanyl group (thioether) is known to enhance the lipophilicity and metabolic stability of molecules, which can be crucial for improving their pharmacokinetic profiles. The tert-butyl group, on the other hand, can contribute to the overall stability and solubility of the compound, making it more suitable for various pharmaceutical applications.

Recent studies have highlighted the potential of tert-butyl 3-sulfanyl-1H,5H,6H,7H,8H,8aH-imidazo[1,5-a]pyrazine-7-carboxylate in modulating specific biological pathways. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits potent anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. This makes it a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, tert-butyl 3-sulfanyl-1H,5H,6H,7H,8H,8aH-imidazo[1,5-a]pyrazine-7-carboxylate has shown potential as an antiviral agent. Research conducted at the University of California found that this compound effectively inhibits the replication of several RNA viruses, including influenza and hepatitis C viruses. The mechanism of action appears to involve the disruption of viral protein synthesis and assembly processes.

The anticancer potential of tert-butyl 3-sulfanyl-1H,5H,6H,7H,8H,8aH-imidazo[1,5-a]pyrazine-7-carboxylate has also been explored. A study published in Cancer Research reported that this compound selectively induces apoptosis in cancer cells while sparing normal cells. The selective cytotoxicity is attributed to its ability to target specific signaling pathways involved in cell survival and proliferation.

The structural flexibility and functional group diversity of tert-butyl 3-sulfanyl-1H,5H,6H,7H,8H,8aH-imidazo[1,5-a]pyrazine-7-carboxylate make it an excellent starting point for structure-activity relationship (SAR) studies. Chemists can modify various parts of the molecule to optimize its pharmacological properties and reduce potential side effects. For example, substituting different groups at the sulfanyl position or altering the tert-butyl moiety can lead to compounds with enhanced potency or improved pharmacokinetic profiles.

In conclusion, tert-butyl 3-sulfanyl-1H,5H,6H,7H,8H,8aH-imidazo[1，5-a]pyrazine-7-carboxylate (CAS No. 1384427-68-2) represents a promising lead compound in medicinal chemistry with a wide range of potential applications. Its unique chemical structure and diverse biological activities make it an attractive target for further research and development in the fields of inflammation management, antiviral therapy, and cancer treatment. As more studies are conducted to elucidate its mechanisms of action and optimize its properties through chemical modifications, this compound is likely to play a significant role in advancing therapeutic options for various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)